This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
thetranscendedman
atranscendedman.bsky.social
did:plc:qwvym2ap4kzgfpyih5mjmnbx
Researchers from Tsinghua University and collaborators developed a new SARS-CoV-2 inhibitor called H102.
It blocks the viral protease at 8.8 nM potency and unusually distorts its catalytic core, stopping replication in cells.
https://journals.asm.org/doi/10.1128/jvi.00658-25
2025-09-15T16:00:00.307Z